茜草的传统应用、化学成分、药理活性与临床应用综述
该综述系统检索CNKI、百度学术、PubMed、Web of Science等数据库及《中国药典》《中华本草》等书籍,汇总茜草的传统用途、化学成分、药理作用与临床应用。茜草含100余种化合物,以醌类与肽类含量最高,具抗肿瘤、抗氧化、抗血小板聚集、抗炎等作用,但多数研究为临床前研究,缺乏药代动力学与毒性数据。
要点
- 茜草含醌类、肽类等100余种化合物,醌类与肽类含量最高。
- 含茜草的方剂临床用于异常子宫出血、原发性痛经等妇科病及过敏性紫癜、肾出血等。
- 药理作用包括抗肿瘤、抗氧化、抗血小板聚集、抗炎,但多为临床前研究。
核心结论
- 茜草传统用于改善血液循环、止血、通络等,现代研究显示其具抗肿瘤、抗氧化、抗血小板聚集、抗炎作用,但机制尚未深入研究。
研究设计与样本
- 综述类:系统检索CNKI、百度学术、PubMed、Web of Science等数据库及相关专业网站,并查阅《中国药典》《中华本草》等书籍。
主要发现
- 茜草中已发现100余种化合物,包括双环肽、萜类、多糖、微量元素、黄酮类和醌类,其中醌类和肽类含量最高。
- 含茜草的许多方剂广泛用于异常子宫出血、原发性痛经等妇科疾病及过敏性紫癜、肾出血等疾病的临床治疗。
- 现代药理研究显示茜草及其衍生成分具有抗肿瘤、抗氧化、抗血小板聚集和抗炎作用。
临床怎么用
- 含茜草方剂可用于异常子宫出血、原发性痛经等妇科疾病及过敏性紫癜、肾出血等,但需注意临床安全数据缺乏。
局限性
- 多数研究为临床前研究,药理机制尚未深入研究。
- 茜草的药代动力学与毒性研究较少,临床安全数据缺乏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rubia cordifolia (family: Rubiaceae) L (R. cordifolia) is a perennial botanical drug climbing vine. As the main part of the traditional Chinese medicine, the rhizome has a long history. A great number of literary studies have reported that it can be used for the improvement of blood circulation, hemostasis, activation of collaterals, etc. When it comes to the wide application of R. cordifolia in traditional medicine, we systematically review its traditional uses, phytochemistry and pharmacological effects. Literatures were systematically searched using several scientific databases, including China National Knowledge Infrastructure (CNKI), Baidu Scholar, PubMed, Web of Science, and other professional websites. Kew Botanical Garden and the iPlant were used for obtaining the scientific names and plant images of R. cordifolia. In addition, other information was also gathered from books including traditional Chinese herbal medicine, the Chinese Pharmacopoeia, and Chinese Materia Medica. So far, many prescriptions containing R. cordifolia have been widely used in the clinical treatment of abnormal uterine bleeding, primary dysmenorrhea and other gynecological diseases, allergic purpura, renal hemorrhage and other diseases. The phytochemistry studies have reported that more than 100 compounds are found in R. cordifolia, such as bicyclic peptides, terpenes, polysaccharides, trace elements, flavonoids, and quinones. Among them, quinones and peptides are the types of components with the highest contents in R. cordifolia. The modern pharmacological studies have revealed that R. cordifolia and its derived components have anti-tumor, anti-oxidative, anti-platelet aggregation, and anti-inflammatory effects. However, most studies are preclinical. The pharmacological mechanism of R. cordifolia has not been thoroughly studied. In addition, there are few pharmacokinetic and toxicity studies of R. cordifolia, therefore the clinical safety data for R. cordifolia is lacking. To sum up, this review for the first time summarizes a systemic and integrated traditional uses, chemical compositions, pharmacological actions and clinical applications of R. cordifolia, which provides the novel and full-scale insight for the drug development, medicinal value, and application of R. cordifolia in the future.
引用
- Wen M, Chen Q, Chen W, et al. A comprehensive review of Rubia cordifolia L.: Traditional uses, phytochemistry, pharmacological activities, and clinical applications. Front Pharmacol. 2022. PMID: 36160419. doi:10.3389/fphar.2022.965390
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。